6 completed, 1 not yet recruiting, 1 recruiting. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Not yet recruiting 1, Recruiting 1 |
Follow Subcutaneous Fat: new trials by email Literature Review of Subcutaneous Fat trials Research Report on Subcutaneous Fat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection - Subcutaneous Fat | Phase 2 | Not yet recruiting | Caliway Biopharmaceuticals Co., Ltd. | 250 | 2027-02-01 | 2026-10-20 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 2 | Recruiting | Caliway Biopharmaceuticals Co., Ltd. | 250 | 2026-06-01 | 2026-10-20 |
| A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 173 | 2023-11-10 | 2024-12-05 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 107 | 2023-05-30 | 2024-07-22 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) CBL-514 Injection, Placebo - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 75 | 2022-02-14 | 2023-04-24 |
| A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 10 | 2022-02-11 | 2026-05-22 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 25 | 2020-12-09 | 2024-08-09 |
| A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 43 | 2020-02-03 | 2021-01-08 |
Sodium Chloride (3)
Caliway Biopharmaceuticals Co., Ltd. (8)
Australia (5) · United States (4)
Anne Sheu (6)